Insights

CJEU rules no authorisation of health claims made on glucose

by Dr. Manja Epping

Fujifilm declarations – High Court rules in favour of FKB in Humira challenge

by Dr Paul England

Rezeptortyrosinkinase II: Patent protection for a test method does not extend to test results

by Dr. Dietrich Kamlah

Calculation of SPC term in EU accession countries

Data exclusivity for innovators - a bridge too far?

by Andrew Payne

Pemetrexed in Germany: Federal Court of Justice sets aside decision of Appeal Court

by Christoph de Coster, LL.M. (UC Davis) and Julius Zacharias

CJEU confirms orphan drug market exclusivity

by Matthew Royle, Ph.D.

Intellectual Property in the Life Sciences, in review

by Dr Paul England

The implementation of the Nagoya Protocol in the EU

by Verena Bertram

High Court grants declaratory relief in pharmaceutical regulatory dispute

by Andrew Payne

The implementation of the Nagoya Protocol in Germany

by Verena Bertram

Upgrading the single market: updating the Bolar exemption

by Dr Paul England